{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:53:07Z","timestamp":1787860387556,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:00:00Z","timestamp":1679875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11845-023-03351-4","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T01:02:47Z","timestamp":1679878967000},"page":"3163-3167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Adherence of patients with age-related macular degeneration to AREDS 2-recommended nutritional supplements"],"prefix":"10.1007","volume":"192","author":[{"given":"Ammr","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Keegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Dooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4851-0918","authenticated-orcid":false,"given":"Louise","family":"O\u2019Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,27]]},"reference":[{"key":"3351_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ophtha.2011.09.027","volume":"119","author":"AR Rudnicka","year":"2012","unstructured":"Rudnicka AR, Jarrar Z, Wormald R et al (2012) Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 119:571\u2013580. https:\/\/doi.org\/10.1016\/j.ophtha.2011.09.027","journal-title":"Ophthalmology"},{"key":"3351_CR2","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1016\/j.ophtha.2016.08.016","volume":"123","author":"MC Gillies","year":"2016","unstructured":"Gillies MC, Nguyen V, Daien V et al (2016) Twelve-month outcomes of ranibizumab vs. aflibercept for neovascular age-related macular degeneration: data from an observational study. Ophthalmology 123:2545\u20132553. https:\/\/doi.org\/10.1016\/j.ophtha.2016.08.016","journal-title":"Ophthalmology"},{"key":"3351_CR3","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Group A-REDSR","year":"2001","unstructured":"Group A-REDSR (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119:1417\u20131436. https:\/\/doi.org\/10.1001\/archopht.119.10.1417","journal-title":"Arch Ophthalmol"},{"key":"3351_CR4","doi-asserted-by":"publisher","unstructured":"Age-Related Eye Disease Study 2 (AREDS2) (2013) Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309:2005\u20132015. https:\/\/doi.org\/10.1001\/jama.2013.4997","DOI":"10.1001\/jama.2013.4997"},{"key":"3351_CR5","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/IAE.0b013e3181cea5c6","volume":"30","author":"BS Hochstetler","year":"2010","unstructured":"Hochstetler BS, Scott IU, Kunselman AR et al (2010) Adherence to recommendations of the Age-Related Eye Disease Study in patients with age-related macular degeneration. Retina 30:1166\u20131170. https:\/\/doi.org\/10.1097\/IAE.0b013e3181cea5c6","journal-title":"Retina"},{"key":"3351_CR6","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jcjo.2013.01.013","volume":"48","author":"SU Shah","year":"2013","unstructured":"Shah SU, Pilli S, Telander DG et al (2013) Survey of patients with age-related macular degeneration: knowledge and adherence to recommendations. Can J Ophthalmol 48:204\u2013209. https:\/\/doi.org\/10.1016\/j.jcjo.2013.01.013","journal-title":"Can J Ophthalmol"},{"key":"3351_CR7","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.3341\/jkos.2021.62.11.1502","volume":"62","author":"JH Na","year":"2021","unstructured":"Na JH, Lim JW, Bang JW et al (2021) Survey of AREDS2 formula intake in Korean patients with age-related macular degeneration. J Korean Ophthalmol Soc 62:1502\u20131508. https:\/\/doi.org\/10.3341\/jkos.2021.62.11.1502","journal-title":"J Korean Ophthalmol Soc"},{"key":"3351_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1442-9071.2006.01141.x","volume":"34","author":"WT Ng","year":"2006","unstructured":"Ng WT, Goggin M (2006) Awareness of and compliance with recommended dietary supplement among age-related macular degeneration patients. Clin Experiment Ophthalmol 34:9\u201314. https:\/\/doi.org\/10.1111\/j.1442-9071.2006.01141.x","journal-title":"Clin Experiment Ophthalmol"},{"key":"3351_CR9","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ophtha.2007.08.003","volume":"115","author":"LD Charkoudian","year":"2008","unstructured":"Charkoudian LD, Gower EW, Solomon SD et al (2008) Vitamin usage patterns in the prevention of advanced age-related macular degeneration. Ophthalmology 115:1032-1038.e4. https:\/\/doi.org\/10.1016\/j.ophtha.2007.08.003","journal-title":"Ophthalmology"},{"key":"3351_CR10","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","volume":"122","author":"PA Newman-Casey","year":"2015","unstructured":"Newman-Casey PA, Robin AL, Blachley T et al (2015) The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology 122:1308\u20131316. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.026","journal-title":"Ophthalmology"},{"key":"3351_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1475-1313.2003.00155.x","volume":"24","author":"S Deokule","year":"2004","unstructured":"Deokule S, Sadiq S, Shah S (2004) Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms. Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt 24:9\u201315. https:\/\/doi.org\/10.1046\/j.1475-1313.2003.00155.x","journal-title":"Ophthalmic Physiol Opt J Br Coll Ophthalmic Opt"},{"key":"3351_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/10807680260362687","volume":"18","author":"SA Taylor","year":"2002","unstructured":"Taylor SA, Galbraith SM, Mills RP (2002) Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther 18:401\u2013409. https:\/\/doi.org\/10.1089\/10807680260362687","journal-title":"J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther"},{"issue":"Pt 2","key":"3351_CR13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/eye.1998.56","volume":"12","author":"AP Rotchford","year":"1998","unstructured":"Rotchford AP, Murphy KM (1998) Compliance with timolol treatment in glaucoma. Eye (Lond) 12(Pt 2):234\u2013236. https:\/\/doi.org\/10.1038\/eye.1998.56","journal-title":"Eye (Lond)"},{"key":"3351_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4065\/mcp.2010.0575","volume":"86","author":"MT Brown","year":"2011","unstructured":"Brown MT, Bussell JK (2011) Medication adherence: WHO cares? Mayo Clin Proc 86:304\u2013314. https:\/\/doi.org\/10.4065\/mcp.2010.0575","journal-title":"Mayo Clin Proc"},{"key":"3351_CR15","first-page":"34","volume":"81","author":"KR Card","year":"2022","unstructured":"Card KR, Golez J, Ing MR (2022) Trends in Hawai\u2019i ophthalmologists\u2019 recommendations to patients for prevention of age-related macular degeneration. Hawai\u2019i J Heal Soc Welf 81:34\u201337","journal-title":"Hawai\u2019i J Heal Soc Welf"},{"key":"3351_CR16","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5301\/ejo.2010.4138","volume":"21","author":"DC Fahed","year":"2011","unstructured":"Fahed DC, Ghazi NG, Jabbour NM et al (2011) Impact of AREDS in a developing country 5 years after publication of the study. Eur J Ophthalmol 21:67\u201372. https:\/\/doi.org\/10.5301\/ejo.2010.4138","journal-title":"Eur J Ophthalmol"},{"key":"3351_CR17","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/bjophthalmol-2017-310939","volume":"102","author":"AY Lee","year":"2018","unstructured":"Lee AY, Butt T, Chew E et al (2018) Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data. Br J Ophthalmol 102:465\u2013472. https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310939","journal-title":"Br J Ophthalmol"},{"key":"3351_CR18","doi-asserted-by":"publisher","unstructured":"Risk factors associated with age-related macular degeneration (2000) A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology 107:2224\u20132232. https:\/\/doi.org\/10.1016\/s0161-6420(00)00409-7","DOI":"10.1016\/s0161-6420(00)00409-7"},{"key":"3351_CR19","doi-asserted-by":"publisher","unstructured":"Gopinath B, Flood VM, Kifley A et al (2015) Smoking, antioxidant supplementation and dietary intakes among older adults with age-related macular degeneration over 10 years. PLoS One 10:e0122548. https:\/\/doi.org\/10.1371\/journal.pone.0122548","DOI":"10.1371\/journal.pone.0122548"},{"key":"3351_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/j.1444-0938.2012.00789.x","volume":"95","author":"RD Kennedy","year":"2012","unstructured":"Kennedy RD, Spafford MM, Behm I et al (2012) Positive impact of Australian \u201cblindness\u201d tobacco warning labels: findings from the ITC four country survey. Clin Exp Optom 95:590\u2013598. https:\/\/doi.org\/10.1111\/j.1444-0938.2012.00789.x","journal-title":"Clin Exp Optom"},{"key":"3351_CR21","unstructured":"AMD awareness week (2022). https:\/\/www.amd.ie\/amd-awareness-week-2022\/. Accessed 15 Jan 2023"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-023-03351-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-023-03351-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T22:20:17Z","timestamp":1701469217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-023-03351-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3351"],"URL":"https:\/\/doi.org\/10.1007\/s11845-023-03351-4","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,27]]},"assertion":[{"value":"19 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the 1963 Declaration of Helsinki and was approved by the clinical audit and effectiveness committee of the Mater Misericordiae University Hospital, Dublin, Ireland.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}